Evangelische Krankenhausstiftung Oldenburg
- Address
- lock Available on a paid plan
Neurology and Emergency Care
At Evangelische Krankenhausstiftung Oldenburg, clinical research in Nervous System Diseases focuses on serious urgent conditions such as status epilepticus and acute ischemic stroke. These studies are designed to strengthen evidence for treatment choices and improve outcomes in time-critical neurological emergencies, especially in older adults and patients with complex medication backgrounds.
- Established status epilepticus in people 65 years and older
- Acute ischemic stroke in patients taking direct oral anticoagulants
- Evaluation of treatment effectiveness and functional recovery in emergency neurological care
The work reflects a strong interest in finding better-supported approaches for high-risk neurological disorders, with a clear emphasis on real-world clinical benefit.
Otolaryngology and Hearing Research
Research in Otorhinolaryngologic Diseases at this site centers on idiopathic sudden sensorineural hearing loss, a condition that can affect hearing abruptly and significantly. The trial activity is aimed at comparing treatment options to see whether hearing outcomes can be improved more effectively for patients with moderate to severe hearing loss.
- Idiopathic sudden sensorineural hearing loss
- Assessment of hearing improvement and treatment response
- Comparing a new local therapy approach with standard steroid treatment
This area highlights the site’s focus on practical clinical questions in ear, nose, and throat medicine, especially where rapid treatment may influence recovery.
Cardiovascular and Stroke Medicine
The Cardiovascular Diseases research at Evangelische Krankenhausstiftung Oldenburg is closely linked to stroke care, with studies examining whether a thrombolytic treatment can improve recovery after acute ischemic stroke. The aim is to generate clearer evidence on treatment effectiveness in patients who are already receiving anticoagulant therapy.
- Acute ischemic stroke outcomes in anticoagulated patients
- Testing whether treatment can improve functional recovery
- Evidence generation for safer, more effective stroke management
This research contributes to the broader field of vascular medicine by addressing a challenging group of patients where treatment decisions must balance benefit and safety.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Universitaet Leipzig1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Evangelische Krankenhausstiftung Oldenburg
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Effectiveness of Levetiracetam and Valproate Semisodium in Benzodiazepine-Resistant Status Epilepticus in Patients Aged 65 and Older | Universitaet Leipzig | Phase III | Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.